STUDY QUESTION: Is recurrent implantation failure (RIF) associated with decreased expression of platelet and endothelial cell adhesion molecule 1 (PECAM1) and transforming growth factor β1 (TGF-β1) in the endometrium during the implantation window?
Introduction
Infertility is a highly prevalent problem. Globally, it affects~186 million individuals, or 8-12% of reproductive-age couples, and its incidence is increasing, imposing a heavy burden on families and society (Inhorn and Patrizio, 2015) . Over the previous decades, ART, especially IVF-embryo transfer (IVF-ET), has experienced rapid development and become an efficient and common therapeutic approach for overcoming infertility (Pandian et al., 2015) . The pregnancy rate of IVF-ET has been significantly improved due to revised induction protocol and new culture system. However, even in the very successful units, some infertile couples fail repeatedly. There are many reasons for implantation failure which include embryonic abnormalities and maternal factors (such as immunological factors and nonreceptive endometrium) (Simon and Laufer, 2012) .
Recurrent implantation failure (RIF), defined as failure to achieve a clinical pregnancy after the transfer of a total of at least four good-quality embryos (score ≥ 7) (Zhang et al., 2012) in a minimum of three fresh or frozen cycles, is a challenging problem in clinical medicine. Structural and chromosomal abnormalities, such as abnormal uterine cavity, hydrosalpinx and abnormal karyotype must be excluded (Coughlan et al., 2014) . Currently, RIF is mainly defined as implantation failure due to poor endometrial receptivity (Davari-Tanha et al., 2016) . Previous studies have shown that the expression levels of various substances, including homeobox A10 (HOXA10) (Yang et al., 2017) , LIF (Choi et al., 2016) , metabolites (RoyChoudhury et al., 2016) and inflammatory cytokines are abnormally expressed in the endometrium or peripheral serum of women with RIF, indicating that these factors are possibly associated with endometrial receptivity (Liang et al., 2015) . At present, the precise pathogenesis of RIF has not been fully elucidated. To develop potential therapeutic approach for RIF, further studies aimed at revealing the exact etiology and pathogenesis of this situation are urgently needed. In the present study, we aimed to investigate the expression levels of PECAM1 and TGF-β1 in the pre-implantation endometrium in women with RIF. We also examined the regulatory role of PECAM1 in modulating the expression of TGF-β1 in an endometrial cell line, as well as in primary HEECs and HESCs.
Materials and Methods

Ethical approval
All participants signed informed consent forms approved by the Shanghai Jiao Tong University Committee on the Use of Human Subjects in Medical
Research. Ethical approval of all tissue collection was obtained from the Institutional Ethics Committee of Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University.
Patients and endometrial biopsies
From January 2014 to December 2016, 40 women aged between 25 and 35 years treated at the Reproductive Medical Center of Ruijin Hospital were enrolled in this study. Women with RIF (no pregnancy after ≥3 embryo transfers including a total of ≥4 good-quality embryos; n = 22) and women with tubal infertility who achieved a clinical pregnancy after the first embryo transfer (controls) (n = 18) were recruited as the two subject groups. The inclusion criteria for both groups were as follows: healthy, regular ovulatory cycles of 28-32 days, normal endocrine profile including normal serum levels of FSH (<10 mIU/mL), LH (<10 mIU/mL) and estradiol (E2 < 50 pg/mL) on Day 3 of the menstrual cycle, during which the research was performed. The exclusion criteria for all participants were: intrauterine pathology (congenital uterine anomaly, fibroid, polyps, intrauterine adhesions), hydrosalpinx, polycystic ovary syndrome (PCOS), endometriosis, adenomyosis, couples with abnormal chromosomal or abortion tissues with abnormal karyotypes, positive for lupus anticoagulant or anticardiolipin antibodies, infectious diseases, endocrine disease (abnormal blood glucose level or thyroid dysfunction) and use of any contraceptive drugs or intrauterine devices within the last 6 months. The exclusion criteria were monitored by using various approaches such as vaginal ultrasonography, hysteroscopy, laparoscope, karyotyping analysis along with relevant hormone and immunological tests. Specimens were obtained on Day LH + 7 (All women were monitored the follicles development using transvaginal ultrasound (Hitachi EUB-2000) until the diameter of the dominant follicle was ≥15 mm, then serum LH and E2 levels were quantified daily. The day on which LH level peaked (≥20 mIU/mL) was deemed to be the day of LH 0; the window phase was defined as the day of LH + 7.) via pipe suction curettage (Wallace) (Xu et al., 2012) .
At the same time, we enrolled 18 women with infertility secondary to tubal factor using the same exclusion and inclusion criteria, as described above. These 18 women were divided into three groups (n = 6 per group): early proliferative phase (Days 4-5 of cycle), late proliferative phase (Days 11-13 of cycle) and mid-secretory phase (Days 20-22 of cycle). Endometrial samples were obtained from these three groups. Six further women, who met the same criteria, were enrolled in December 2017 to obtain mid-secretory phase endometrial tissue samples used for isolation of primary HEECs and HESCs.
Whole-genome expression profile analysis
The Affymetrix GeneChip ® PrimeView™ Human Gene Expression Array (Thermo Fisher Scienfitic, USA) was used to examine the whole-genome expression profiles of three women from the control and RIF groups. Total RNA was isolated using TRIzol according to the manufacturer's instructions (Takara, China) and was purified using an RNeasy Mini Kit (Qiagen, Germany). The RNA integrity number (RIN) was 8-10 and the ratio of 28 S/18 S was between 1.7 and 2.1. Each RNA sample (25 μg) was used to generate biotinylated chromosomal RNA targets for the gene expression array and then hybridized with the microarrays. Arrays were stained using the GeneChip Fluidics Station 450 and were scanned on the GeneChip Scanner 3000. Raw probe intensities were normalized and background-adjusted using affy package in R. Principle components analysis (PCA), differential expression analysis, and functional enrichment analysis were carried out according to previously published methods (Xu et al., 2017) .
Reverse transcription quantitative real-time PCR
Total RNA was extracted from the samples using TRIzol (Invitrogen, USA) according to the manufacturer's instructions, and the RNA was reversetranscribed using PrimeScript ™ RT Master Mix (Takara). Reverse transcription quantitative real-time PCR (RT-qPCR) was performed using SYBR Green Master Mix (Takara) on an Applied Biosystems 7500 Realtime PCR System (USA); Supplementary Table SI lists the primers for RTqPCR used in this study. The mRNA expression levels were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and calculated using the comparative threshold cycle (2 −ΔΔCt ) method. Each sample was analyzed in triplicate, and all tests were repeated at least three times.
Protein preparation and western blotting
Total protein was extracted from snap-frozen endometrial samples that had been homogenized, and tissues or cells were incubated on ice with radio-immuno precipitation assay (RIPA) lysis buffer with protease inhibitors (Thermo Fisher Scientific). Protein extracts were obtained after centrifuging the samples at 12 000g for 20 min at 4°C. Protein concentrations were measured using a bicinchoninic acid assay (BCA) assay kit (Beyotime Biotechnology, China). Equal amounts of protein (100 μg) were separated using 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, USA). Membranes were blocked in 5% w/v non-fat milk for 1 h at room temperature, and then incubated at 4°C overnight with the following specific primary antibodies: ICAM2 (13355, Cell Signaling Technology, USA, 1:1000), ITGB2 (sc-8420, Santa Cruz, USA, 1:100), PECAM1 (sc-376764, Santa Cruz, 1:100), SELP (sc-8419, Santa Cruz, 1:100), TEK (NBP1-18614, Novus Biologicals, USA, 1:500), HOXA10 (ab191470, Abcam, UK, 1:1000), TGFB1 (ab92486, Abcam, 1:250). GAPDH (5174, Cell Signaling Technology, 1:1000) was used as the internal control. After washing the membranes four times with 0.1% v/v Tween in Tris-buffered saline (TBST), membranes were incubated with the corresponding horseradish peroxidase (HRP)-conjugated secondary antibodies (Beyotime Biotechnology, 1:1000). Target proteins were detected using enhanced chemiluminescence (ECL) according to the manufacturer's (Millipore) instructions.
Immunohistochemical staining
Paraffin-embedded endometrial tissue sections (5 μm) were dewaxed in xylene, rehydrated in graded ethanol through to phosphate-buffered saline (PBS), and quenched in 3% v/v hydrogen peroxide for 10 min to inhibit endogenous peroxidase activity. Antigen retrieval was performed in a microwave oven with 0.01 M sodium citrate buffer. The sections were blocked with 5% w/v bovine serum albumin (Amresco, USA) for 20 min at room temperature, and then were incubated overnight at 4°C with primary antibody against PECAM1 (sc-376764, Santa Cruz, 1:100) or TGFB1 (ab92486, Abcam, 1:100). Next, the slides were washed in PBS twice and were incubated with the corresponding secondary antibodies (Beyotime Biotechnology, 1:1000). Then, the specific antibody signal was visualized by incubation with diaminobenzidine (DAB; Dako, France) and counterstaining with hematoxylin. The immunostaining was repeated on sections from the same biopsy in triplicate. Mouse and rabbit non-immune immunoglobulin G (IgG) was substituted for the primary antibody in the negative controls. The slides were visualized using a Nikon Eclipse 80i microscope for bright-field imaging (Nikon Inc., Japan).
Immunofluorescence and co-localization
Endometrial tissues were cut into~5 mm × 5 mm × 5 mm pieces and embedded in OCT compound (Tissue Tek, USA). Then, the frozen blocks were cut into 8-μm serial sections at −22°C using a Leica CM3050 cryostat (Switzerland) and were air-dried for 30 min at room temperature on gelatin-coated slides. The sections were fixed in cold 100% acetone for 10 min and were washed in PBS for 5 min, blocked using 5% w/v bovine serum albumin (Amresco) in PBS for 30 min at room temperature, and incubated with primary antibodies against PECAM1 (sc-376764, Santa Cruz, 1:100) and cytokeratin 7 (ab181598, Abcam, 1:8000) or vimentin (ab92547, Abcam, 1:100) overnight at 4°C. The sections were washed in PBS (3 × 15 min) and incubated with secondary antibodies conjugated to Alexa 555 (A-31572, Life Technologies, USA, 1:400) or Alexa 488 (A-21202, Life Technologies, 1:400) for 1 h at room temperature, and were washed in PBS (3 × 15 min). After washing, coverslips were mounted with Vectashield medium (Vector Laboratories, USA). The slides were examined using an Olympus BX53M fluorescence microscope (Japan).
Culture of Ishikawa cells, primary HEECs and HESCs
Ishikawa cells, a human endometrial adenocarcinoma cell line, were purchased from European Collection of Authenticated Cell Cultures (ECACC). Isolation of primary HEECs and HESCs was performed according Zhang et al. (2012) . All these cells were cultured in DMEM/F12 medium (Hyclone, USA) supplemented with 10% (v/v) heat inactivated fetal bovine serum (Gibco, USA) and 1% v/v penicillin/streptomycin (Gibco). Cells were incubated at 37°C in humidified air with 5% CO 2 and were harvested by brief incubation in 0.25% (w/v) Trypsin-EDTA (Gibco).
shRNA transfection PECAM1 was knocked-down in Ishikawa cells, primary HEECs and HESCs by transfecting PECAM1 shRNA plasmid and the negative control group was transfected using a non-silencing scramble shRNA plasmid (GeneCopoeia, Inc., USA). The effective target sequence for PECAM1 shRNA was 5′-GGAAGATACGATTGTGTCACA-3′, and the scramble shRNA sequence was 5′-GCTTCGCGCCGTAGTCTTA-3′. Cells were transfected with plasmids and transfection reagent Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Briefly, cells were seeded in six-well plates and were incubated overnight. When cells reached 70% confluence, 4 μg of plasmid and 10 μL of Lipofectamine 2000 were diluted with 500 μL Opti:MEM medium (Gibco, USA) and incubated at room temperature for 25 min, then the transfection complex were added to the cells in 1.5 mL Opti:MEM medium per well. After 6 h, the medium was replaced by fresh complete growth medium.
Statistical analysis
Data are represented as the mean ± SD. Statistical analyses were conducted using the SPSS 22.0 software (SPSS Inc., USA). Characteristics were compared between the RIF and control groups using a two-tailed Student t-test and Fisher's exact test; the characteristics of different menstrual cycle groups were analyzed using one-way ANOVA. Differences with P < 0.05 were considered statistically significant.
Data availability
The microarray raw data have been uploaded to NCBI GEO under accession number of GSE103565 (Review private link https://www.ncbi.nlm. nih.gov/geo/query/acc.cgi with token mpofsoqazjcjhyb).
Results
Demographics Table I summarized the demographic characteristics of the study subjects; there was no significant difference (i.e. P > 0.05) among the six groups except for the number of embryo transfers.
Microarray expression
According to the normalized data, PCA showed two significant clusters for the control and RIF groups (Fig. 1A) . Among the probe sets, 2519 differentially expressed genes (DEGs) in the RIF group exhibited a fold change of >2 and an adjusted P-value of <0.05; all DEGs were clustered using a hierarchical clustering algorithm (Fig. 1B) , and the gene expression pattern of the RIF group was significantly different from that of the control group. Of the 2591 DEGs, 1809 were upregulated and 710 were down-regulated (Fig. 1C) . GO analysis clustered these genes into groups based on their biological processes (Fig. 1D ), molecular functions ( Fig. 1E ) and cellular components (Fig. 1F) . Notably, 'cell adhesion' and 'adhesion' were the largest proportion of enriched GO terms. To further identify the key cell adhesion molecule (CAM) highly related to RIF, genes annotated with key word 'adhesion' were retrieved from Gene Ontology Consortium (http://www.geneontology.org/) (The Gene Ontology Consortium, 2017) and totally 393 unique genes were screened. Next, we did deep text mining with these gene names, searching against NCBI Gene database, PubMed database, Uniprot database (The UniProt Consortium, 2017) and GeneCards database (Stelzer et al., 2016) . After massive literature review and database searching, five CAMs were reported to be associated with embryo implantation that had not been studied in RIF, including ICAM2, ITGB2, PECAM1, SELP and TEK, which were selected for further study.
Validation of CAMs in the RIF group and the control group
Microarray data showed that ICAM2, ITGB2 and SELP were up-regulated, and PECAM1 and TEK were down-regulated in the RIF group compared with the control group. However, the RT-qPCR results showed mRNA expression levels of the five molecules were all decreased significantly in the RIF group (SELP, TEK P < 0.05; ICAM2, ITGB2 P < 0.01; PECAM1, P < 0.001). Western blotting showed a significant decrease in the protein expression level of PECAM1 in the RIF group (P < 0.05), while no obvious difference was found in the expression of other proteins, respectively (P > 0.05; Fig. 2 ). These results showed that the mRNA and protein levels were consistent only for PECAM1.
PECAM1 was localized in the epithelial and stromal cells of the endometrial tissue Mid-secretory phase endometrium for isolation of primary HEECs and HESCs (n = 6) P value Age (y) 30.5 ± 2.8 30.9 ± 2.9 31.5 ± 2.7 30.8 ± 1.5 30.2 ± 2.6 29.3 ± 2.7 NS a BMI (kg/m 2 ) 22.1 ± 1.9 21.9 ± 1.6 20.8 ± 1.8 22.1 ± 2.2 21.7 ± 2.0 21.1 ± 1.7 NS a FSH (mIU/mL) 7.4 ± 1.5 7.1 ± 1.4 7.7 ± 1.6 6.3 ± 2.4 6.9 ± 1.4 7.2 ± 1.5 NS a LH (mIU/mL) 4.7 ± 1.8 4.0 ± 1.9 4.2 ± 1.4 3.7 ± 1.7 3.2 ± 1.8 3.5 ± Data presented as numbers (%) or means ± SD. Differences with P < 0.05 were considered statistically significant. NC, normal fertile control; RIF, recurrent implantation failure; HEECs, human endometrial epithelial cells; HESCs, human endometrial stromal cells; E2, estradiol; NS, not significant. weaker in the RIF group, consistent with the results from western blotting (Fig. 3) . Cytokeratin 7 and vimentin are biomarkers of endometrial epithelial and stromal cells, respectively (Wang et al., 2012) . Double immunofluorescence staining showed that PECAM1 was co-expressed with cytokeratin 7 and vimentin in the controls (Fig. 4) .
PECAM1 and HOXA10 protein expression levels in the menstrual cycle
To evaluate the functional role of PECAM1 in embryo implantation, we measured PECAM1 protein expression during the menstrual cycle and compared it with the expression of HOXA10, an endometrial receptivity marker. PECAM1 protein expression level increased gradually from the early to late proliferative phases, with a peak level in the mid-secretory phase (P < 0.01, Fig. 5A and B) . The expression of HOXA10 kept at a low level in early proliferative phase, then increased in late proliferative phase and maintained at a high level in the mid-secretory phase. (P < 0.01, Fig. 5C and D) In addition, the expression of HOXA10, at both the mRNA level (P < 0.05) or the protein level (P < 0.01), was significantly lower in the RIF group than in the control group (Fig. 5E-G ).
TGF-β1 expression level were decreased significantly in the RIF group
We measured the expression of TGF-β1 at the mRNA and protein level in the RIF group and control group, respectively. Our data showed that the expression levels of TGF-β1, both mRNA and protein, were significantly lower (P < 0.05) in the RIF group than those in the control group (Figs 6 and 7) .
Knockdown of PECAM1 decreased TGF-β1 expression level in Ishikawa cells, as well as in primary HEECs and HESCs
We used Ishikawa cells to examine the effect of knockdown PECAM1 on the expression of TGF-β1. The results showed that knockdown of PECAM1 led to significantly decreased (P < 0.05) expression of TGF-β1 ( Fig. 8A and B) . Similar results were found in primary HEECs and HESCs (P < 0.05; Fig. 8C-F) . 
Discussion
RIF is still a common and challenging problem for many patients and their physicians. Whereas the causes of RIF are complex, multiple factors, such as poor embryo quality, abnormal chromosome karyotype, abnormal immunity, intrauterine adhesion and low endometrial receptivity, might contribute to the implantation failure. Some researchers thought that RIF was mainly related to poor endometrial Figure 2 The expression of ICAM2, ITGB2, PECAM1, SELP and TEK in the control group and recurrent implantation failure (RIF) group. Samples of six women from the control group (n = 3) and RIF group (n = 3) were used for microarray assay. The mRNA and protein expression of these genes were verified in the samples of 18 women from the control group and 22 women from the RIF group. Microarray, RT-qPCR, western blot. and densitometric quantification were performed for (A) ICAM2, (B) ITGB2, (C) PECAM1, (D) SELP and (E) TEK. Representative western blot results for the control group and RIF group were shown. mRNA expression levels were normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA. GAPDH was used as the loading control. ICAM2, intercellular adhesion molecule 2; ITGB2, integrin subunit beta 2; PECAM1, platelet and endothelial cell adhesion molecule 1; SELP, selectin P; TEK, TEK receptor tyrosine kinase. Data are represented as the mean ± SD. Significance was determined using the two-tailed Student t test. *P < 0.05; **P < 0.01; ***P < 0.001. receptivity (Davari-Tanha et al., 2016) . In this study, we, for first time, found that the expression levels of PECAM1 and its downstream target, TGF-β1, were down-regulated in the mid-secretory phase endometrium of women with RIF undergoing IVF-ET.
Embryo implantation is a complicated process located at the fetalmaternal interface that involves apposition, adhesion, penetration, and invasion of the embryo to the endometrial lining (Enders and Schlafke, 1969) . Apposition is the very first, albeit loose, connection between the embryo and the endometrium. By comparison, adhesion is a much stronger attachment than apposition. During the window of implantation phase, many molecules, including inflammatory cytokines, CAMs, prostaglandins, and mucins are required for embryo implantation. In particular, the CAMs are considered to play a vital role in embryo apposition and adhesion during implantation (van Mourik et al., 2009; Zhang et al., 2013) . The CAM family consists of four members: integrins, cadherins, selectins and immunoglobulins. For example, the ITGB3 subunit, which facilitates trophoblast adhesion to the endometrium during blastocyst implantation, is expressed on the endometrial epithelium during the mid-secretory phase. Aberrant expression of ITGB3 is related to recurrent pregnancy loss and unexplained infertility (Liu et al., 2012) . E-cadherin can establish adhesion junctions between endometrial epithelial cells, and its deficiency in the uterus might result in implantation failure due to abnormal cellular structure (Reardon et al., 2012) . It has been proposed that L-selectin is expressed at human blastocysts, and its ligand oligosaccharides have been found on the endometrial epithelium. L-selectin can modulate the initial adhesion of blastocysts to the maternal epithelium (Genbacev et al., 2003) .
Interestingly, we performed whole genome expression profiling and identified cell adhesion-associated genes as the key regulators in RIF. By text mining using comprehensive databases, we identified five novel CAMs that might be related to embryo implantation, i.e. ICAM2, ITGB2, PECAM1, SELP and TEK. ICAM2 is involved in early pregnancy in rats (Lecce et al., 2013) . ITGB2 expression increased in the mid-secretory endometrium compared with proliferative-phase endometrium (Sundqvist et al., 2012) . PECAM1 has been detected by transcriptome analysis, which found that it is restricted to the receptive endometrium (Haouzi et al., 2011) . SELP plays a role in bovine conceptus implantation (Bai et al., 2015) . TEK expression is higher in endometrial carcinoma, in which the characteristics of proliferation and invasion are similar to those in embryo implantation (Saito et al., 2007) . Our microarray results showed that ICAM2, ITGB2 and SELP were up-regulated, while PECAM1 and TEK Figure 5 The protein expression of PECAM1 and HOXA10 in the different menstrual phase of women with secondary infertility, and the expression of HOXA10 in the control group and recurrent implantation failure (RIF) group. (A and C) Representative western blot analysis and (B and D) densitometric quantification of PECAM1 and HOXA10 in the different menstrual phase endometrium of fertile women (n = 6 per group). (E) RT-qPCR, (G) representative western blot analysis and (F) densitometric quantification of HOXA10 in the endometrium of the control group (n = 18) and RIF group (n = 22). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the loading control. EP, early proliferative phase; LP, late proliferative phase; MS, mid-secretory phase; Data are represented as the mean ± SD. Significance was determined using the one-way ANOVA and two-tailed Student t test. *P < 0.05; **P < 0.01.
were down-regulated. Further validation by RT-qPCR and western blotting showed that only the mRNA and protein levels of PECAM1 were consistent, and were significantly lower in the RIF group than those in the control group, respectively. Accordingly, the results showed that the decreased PECAM1 expression might have a potential role in the occurrence of RIF.
We further used immunohistochemistry and double immunofluorescence to determine the localization of PECAM1 in the endometrium. The results showed that the expression level of PECAM1 was much lower in the RIF group compared to the control group, which was consistent with the results from RT-qPCR and western blotting. Furthermore, PECAM1 was localized in the epithelial and stromal cells of the endometrium. To investigate the relationship between PECAM1 and endometrial receptivity, we performed western blotting using endometrial tissues at different stages throughout the menstrual cycle in normal women. We found that PECAM1 protein expression level increased gradually with a peak in the mid-secretory phase. Interestingly, the expression pattern of HOXA10, a marker of endometrial receptivity, increased during late proliferative phase and maintained at a high level in the mid-secretory phase (Daftary and Taylor, 2004) . The results indicated that the increased-expression of PECAM1 and/or HOXA10 in mid-secretory phase during the menstrual cycle was in favor of embryo implantation. In other words, decreased expression of PECAM1 and/or HOXA10 might be harmful to endometrial receptivity.
PECAM1, also known as CD31, is a 130-kD transmembrane glycoprotein that is one of the CAM family members. It is involved in a variety of biological processes, such as cellular adherence, leukocyte migration, and the inflammatory and immune responses (Jackson, Figure 6 The expression of TGF-β1 in the control group and recurrent implantation failure (RIF) group. (A) RT-qPCR, (C) representative western blot analysis and (B) densitometric quantification of TGF-β1 in the endometrium of the control group (n = 18) and RIF group (n = 22). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the loading control. Data are represented as the mean ± SD. Significance was determined using the two-tailed Student t test. *P < 0.05. Figure 7 Immunohistochemistry analysis of paraffin-embedded endometrial tissues. TGF-β1 expression in the endometrium of (A) control women and (B) recurrent implantation failure (RIF) patients. (C) The negative control stained with a rabbit non-immune immunoglobulin G (IgG) showed no brown staining. Original magnification, ×400. Scale bar = 50 μm.
2003). Apart from its role in maintaining vascular integrity, PECAM1 is considered a cellular mechanosensor (Tzima et al., 2005) . Moreover, PECAM1 is involved in regulating various biological processes, such as cell proliferation, apoptosis and tumor metastasis (DeLisser et al., 2010; Raskopf et al., 2014; Cheung et al., 2015) . To date, the functional role of PECAM1 in the regulation of embryo implantation is poorly understood. In this regard, we hypothesize that PECAM1 might facilitate embryo implantation through three aspects. Firstly, as a CAM, the adhesive function of PECAM1 is indispensable to embryo implantation. Secondly, inflammation is a fundamental element in the establishment of endometrial receptivity and a successful embryo implantation (Granot et al., 2012) . Therefore, the pro-inflammatory effect of PECAM1 might facilitate the inflammatory process. Lastly, the functional role of PECAM1 in regulating the biological processes, including cell proliferation, apoptosis and metastasis may be vital to embryo implantation.
TGF-β1, a multifunctional cytokine belonging to the TGF superfamily, is localized in the endometrial epithelial and stromal cells and in decidual cells (Bischof and Campana, 2000) . The cytokine plays an essential role in embryo implantation by improving endometrial stromal cell proliferation, promoting trophoblast cell adherence to maternal endometrium (Feinberg et al., 1994) and increasing trophoblast cell invasiveness (Singh et al., 2011; Maurya et al., 2013) . Furthermore, Rajaei et al. (2011) found that endometrial stromal cells and whole endometrial cells of RIF group produced lower level TGF-β1 compared to normal fertile women, which demonstrated that disorder in the expression of TGF-β1 at the fetal-maternal interface might potentially associate with embryo implantation failure. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the loading control. Data are represented as the mean ± SD. Significance was determined using the two-tailed Student t test. *P < 0.05.
Studies have demonstrated that TGF-β1 could closely interact with PECAM1. The increased transcript level of PECAM1 were observed in cultured sinusoidal endothelial cells and mononuclear phagocytes obtained from normal rat livers after treatment with TGF-β1 (Neubauer et al., 2008) . In human T cells, PECAM1 can enhance T cell sensitivity to TGF-β1 and facilitate the TGF-β1 signaling (Newman et al., 2016) . However, the relationship between the two factors is ambiguous. In this study, we found that the expression levels of PECAM1 and TGF-β1 were significantly lower in the RIF group. Further, we uesd Ishikawa cells to conduct shRNA-transfection knockdown experiment, the result showed that decreased expression of PECAM1 led to lower expression level of TGF-β1. In addition, after knocking down PECAM1 in primary HEECs and HESCs, the expression level of TGF-β1 decreased as well. According to these results, we suggested that TGF-β1 was the downstream factor of PECAM1 and the expression of which was mediated by PECAM1.
In conclusion, we found that the expression of PECAM1 showed dynamic changes during the menstrual cycle, and the expression levels of PECAM1 and TGF-β1 were significantly lower in the mid-secretory endometrium of women with RIF. We also found that TGF-β1 was mediated by PECAM1. Our results suggest that decreased PECAM1-mediated TGF-β1 expression plays an important role in women with RIF. In further study, we will focus on the underlying mechanisms by which decreased PECAM1 and TGF-β1 expression decreases endometrial receptivity in the women with RIF.
